by: TwistedSifter
Homeowner Refuses To Pay Gardener For His Work, So The He Fills The Owner's Yard With Tennis Balls
by: GhanaWeb
Revocation of Licence: Read the letter Bank of Ghana sent to founder of defunct UT Bank
by: Goodreturns
1:10 Stock Split of Pharma Stock: Record Date Set For March 21; What Investors Should Do Next?
by: Vanguard
Accelerating Action: Yetunde Sonowo's trailblazing journey in finance, leadership, real estate
by: Entrepreneur
Women's Day 2025: Celebrating Progress, Demanding Action in Investment and Leadership
by: Ukrinform
Finance Ministry: Partners more willing to engage in dialogue on use of Russian assets
by: MarketWatch
State Street's private-debt ETF launched with major buzz. What are investors getting?
by: Fortune
by: BusinessTech
Sage Intacct - The industry-leading cloud finance software for South African businesses
by: TechCrunch
Turing, a key coding provider for OpenAI and other LLM producers, raises $111M at a $2.2B valuation
by: Deadline
Hims & Hers to shut down dermatology business Apostrophe
Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday.

Read the Full Reuters Article at:
https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-shut-down-dermatology-business-apostrophe-2025-03-07/
on: Wed, Mar 05th 2025
by: manilatimes
Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance
on: Sat, Mar 01st 2025
by: MSN
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?
on: Thu, Feb 20th 2025
by: MSN
Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) Q4 2024 Earnings Call Transcript
on: Wed, Feb 19th 2025
by: Reuters
on: Thu, Feb 13th 2025
by: Reuters
on: Mon, Feb 10th 2025
by: MSN
on: Wed, Feb 05th 2025
by: MSN
on: Tue, Jan 28th 2025
by: AOL
on: Mon, Jan 27th 2025
by: MSN
Three Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
on: Thu, Jan 09th 2025
by: MSN
on: Tue, Dec 03rd 2024
by: Bill Williamson
Jack Nathan Health Closes Sale of Canadian Business and Positions for Global Growth
